Resverlogix Corp. J (TSE:RVX)
TSX:RVX
Holding TSE:RVX?
Track your performance easily

Resverlogix (RVX) Stock Price & Analysis

28 Followers

RVX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.54%99.46%
― Other Institutional Investors
99.46% Public Companies and
Individual Investors

RVX FAQ

What was Resverlogix Corp. J’s price range in the past 12 months?
Resverlogix Corp. J lowest stock price was C$0.04 and its highest was C$0.10 in the past 12 months.
    What is Resverlogix Corp. J’s market cap?
    Currently, no data Available
    When is Resverlogix Corp. J’s upcoming earnings report date?
    Resverlogix Corp. J’s upcoming earnings report date is Mar 27, 2025 which is in 141 days.
      How were Resverlogix Corp. J’s earnings last quarter?
      Resverlogix Corp. J released its earnings results on Aug 14, 2024. The company reported -C$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.022.
        Is Resverlogix Corp. J overvalued?
        According to Wall Street analysts Resverlogix Corp. J’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Resverlogix Corp. J pay dividends?
          Resverlogix Corp. J pays a Notavailable dividend of C$0.4 which represents an annual dividend yield of N/A. See more information on Resverlogix Corp. J dividends here
            What is Resverlogix Corp. J’s EPS estimate?
            Resverlogix Corp. J’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Resverlogix Corp. J have?
            Resverlogix Corp. J has 278,000,180 shares outstanding.
              What happened to Resverlogix Corp. J’s price movement after its last earnings report?
              Resverlogix Corp. J reported an EPS of -C$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 33.333%.
                Which hedge fund is a major shareholder of Resverlogix Corp. J?
                Currently, no hedge funds are holding shares in TSE:RVX
                ---

                Resverlogix Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -7.14%
                12-Months-Change

                Fundamentals

                Return on Equity
                Trailing 12-Months
                Asset Growth
                -0.53%
                Trailing 12-Months

                Company Description

                Resverlogix Corp. J

                Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Revive Therapeutics
                Reliq Health Technologies
                Microbix Biosystms
                Covalon Technologies
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis